1. Home
  2. Mandates
  3. Vinge advises Active Biotech on rights offering (1)

Mandate Vinge advises Active Biotech on rights offering

November 24, 2014

Active Biotech AB (publ) (Nasdaq Stockholm) carries out a rights offering of SEK 225 million. Vinge advises Active Biotech.

The Vinge team primarily consists of Erik Sjöman (partner, capital markets & public M&A) and associates Christian Lindhé, Ludvig Frithiof and Madelene Eriksson.

Compliance policies and dawn raid manuals should be revised in light of amendments to the Swedish Competition Act

As previously described, the Swedish Competition Act (2008:579) will be amended in several important respects on 4 February 2021. We recommend that you revise your current compliance policies and manuals for dawn raids to ensure adherence with the new rules.
November 25, 2020

Jerker Kjellander is a new partner in Skåne

 Dispute resolution expert Jerker Kjellander has been elected as a partner in Vinge’s Skåne office.
November 20, 2020

Amendments to the Swedish Competition Act provide extended powers for the Swedish Competition Authority

Early in 2021, the Swedish Competition Act (2008: 579) will be amended in several important respects. The background to the amendments is Directive (EU) 2019/1 of the European Parliament and of the Council, which aims to harmonize the investigative and sanctioning powers of the European competition authorities in their enforcement of the EU competition rules. Undertakings active in Sweden will be affected by the amendments in several ways.
October 12, 2020